The group's product insulin degludec and liraglutide injection marketing registration application been accepted

聯邦制藥國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 3933) THE GROUP’S PRODUCT INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION MARKETING REGISTRATION APPLICATION BEEN ACCEPTED This announcement is made by The United Laboratories International Holdings Limited (the “Company”) on a voluntary basis. The board of directors (the “Board”) of the Company is pleased to announce